WeVote
Log In

Bill

Bill

SB 576

TO AMEND THE COVERAGE OF CONTINUOUS GLUCOSE MONITORS WITHIN THE ARKANSAS MEDICAID PROGRAM.

2025 Regular Session Introduced by Breanne Davis and 1 co-sponsor

Arkansas Medicaid now covers continuous glucose monitors for more diabetic patients, improving access to real-time blood sugar monitoring technology for low-income residents.

Notification that SB576 is now Act 623
0
WeVote Research Nonpartisan
Bill Summary · SB 576

Legislative bill overview

SB 576 amends Arkansas's Medicaid program to expand coverage of continuous glucose monitors (CGMs), medical devices that track blood sugar levels in real-time. The bill, now enacted as Act 623, modifies eligibility requirements or coverage parameters for these devices under the state's Medicaid system.

Why is this important

Continuous glucose monitors significantly improve diabetes management and health outcomes, particularly for people with Type 1 diabetes and some Type 2 diabetes patients. Expanding Medicaid coverage removes financial barriers for low-income Arkansans who rely on the program, potentially reducing emergency hospitalizations and long-term diabetes complications while improving quality of life.

Potential points of contention

  • Program costs: Expanded CGM coverage increases Medicaid expenditures, raising questions about budget sustainability and whether funds come from other healthcare services
  • Eligibility criteria: The specific populations covered (Type 1 only vs. broader Type 2 inclusion) affects how many beneficiaries gain access and the associated fiscal impact
  • Device selection: Whether the law allows beneficiaries to choose among available CGM manufacturers or restricts options to control costs

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.